Open AccessThis article is
- freely available
Discovery of a Novel CCR5 Antagonist Lead Compound Through Fragment Assembly
School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, P.R. China
The National Center for Drug Screening, Chinese Academy of Sciences, Shanghai 201203, P.R. China
School of Biotechnology, Southwest University, Chongqing 400715, P.R. China
Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, P.R. China
* Authors to whom correspondence should be addressed.
Received: 30 September 2008; in revised form: 18 September 2008 / Accepted: 18 September 2008 / Published: 1 October 2008
Abstract: CCR5, as the major co-receptor for HIV-1 entry, is an attractive novel target for the pharmaceutical industry in the HIV-1 therapeutic area. In this study, based on the structures of maraviroc and 1,4-bis(4-(7-chloroquinolin-4-yl)piperazin-1-yl)butane-1,4-dione (1), which was identified using structure-based virtual screening in conjunction with a calcium mobilization assay, a series of novel small molecule CCR5 antagonists have been designed and synthesized through fragment assembly. Preliminary SARs were obtained, which are in good agreement with the molecular binding model and should prove helpful for future antagonist design. The novel scaffold presented here might also be useful in the development of maraviroc-derived second generation CCR5 antagonists.
Keywords: CCR5 antagonist; fragment assembly; HIV-1; molecular modeling
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Liu, Y.; Zhou, E.; Yu, K.; Zhu, J.; Zhang, Y.; Xie, X.; Li, J.; Jiang, H. Discovery of a Novel CCR5 Antagonist Lead Compound Through Fragment Assembly. Molecules 2008, 13, 2426-2441.
Liu Y, Zhou E, Yu K, Zhu J, Zhang Y, Xie X, Li J, Jiang H. Discovery of a Novel CCR5 Antagonist Lead Compound Through Fragment Assembly. Molecules. 2008; 13(10):2426-2441.
Liu, Yanqing; Zhou, Enkun; Yu, Kunqian; Zhu, Jin; Zhang, Yu; Xie, Xin; Li, Jian; Jiang, Hualiang. 2008. "Discovery of a Novel CCR5 Antagonist Lead Compound Through Fragment Assembly." Molecules 13, no. 10: 2426-2441.